Results 141 to 150 of about 31,760 (183)

Prioritizing cefuroxime as empirical treatment in acute bacterial prostatitis: patient characteristics and outcome. [PDF]

open access: yesJAC Antimicrob Resist
Lecomte E   +6 more
europepmc   +1 more source

Metabolism Profiles of Trimethoprim in Idiosyncratic Adverse Drug Reaction-Affected Tissues. [PDF]

open access: yesChem Res Toxicol
Tessman RT   +3 more
europepmc   +1 more source

Head Lice Infestation: Single Drug Versus Combination Therapy With One Percent Permethrin and Trimethoprim/Sulfamethoxazole

Pediatrics, 2001
Background. Head lice infestation (HLI) is a vexing problem for pediatricians and families because lice are becoming resistant to approved antipediculosis agents. Objective.
R B, Hipolito   +4 more
openaire   +2 more sources

Micellar Electrokinetic Chromatography as a Valuable Technique for the Quality Control of Drugs Based on the Combination of Sulfamethoxazole with Trimethoprim

Chromatographia, 2003
A micellar electrokinetic chromatographic method is presented for the determination of sulfanilic acid and sulphanilamide as degradation products of sulfamethoxazole and of 3,4,5-trimethoxybenzoic acid as degradation product of trimetoprim, by using 15 mM phosphate buffer (pH 12.6), 20 mM sodium dodecylsulfate and 5% (v/v) acetonitrile as electrolyte ...
Berzas Nevado, Juan José   +2 more
openaire   +2 more sources

Risk-benefit analyses of drugs: Fundamental considerations and requirements from the point of view of the biometrician. Problems in the assessment of the combination of trimethoprim with sulfamethoxazole

Infection, 1987
Risk-benefit analyses are a prerequisite for a rational decision about therapies, e.g. drugs. Ingredients of a risk-benefit analysis are: 1. quality and quantity of the benefit; 2. quality and quantity of the harm; 3. benefit and harm of the natural history of the disease; 4. benefit and harm of therapeutic alternatives; 5. commensurability of harm and
J, Hasford, N, Victor
openaire   +2 more sources

Home - About - Disclaimer - Privacy